2026 NPPES data Internal Medicine Physician NPI 1831225606 MD PHD
Verify on CMS →

Matt Wachsman, MD PHD

Internal Medicine Physician in Havre De Grace, Maryland.

This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 172,737 in Internal Medicine Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.

Federal data, no proprietary rating. We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
771
Medicare Part D claims · 49 beneficiaries · Internal Medicine Physician avg: 3K
Generic prescribing
81%
generic claims · 19% brand-name · higher generic rates reduce patient out-of-pocket costs

What the federal data shows

Matt Wachsman, MD PHD filed 771 Medicare Part D claims in 2023 as an Internal Medicine Physician in Havre De Grace, Maryland, prescribing 81% generic.

771
Part D claims, 2023
81%
generic prescribing

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.

Matt Wachsman, MD PHD's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023, across all CMS prescribers nationally

771 Top 29% higher than 71% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). Below this entry. 600–800: 56,224 prescribers (4%). This entry sits in this band. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2K+: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board-eligible specialty (heuristic, not verified)

Matt Wachsman, MD PHD practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about Matt Wachsman, MD PHD?

Quality data not reported

NPI registry status

Active

Issued 02/26/2007

NPI 1831225606

Primary specialty

Internal Medicine Physician

High-volume

172,737 US NPIs in this specialty

Medicare Part D claims

771 72% vs specialty avg

2023 prescription claims

Specialty avg: 2,716

Specialty distribution in Maryland

How Internal Medicine Physician compares to other specialties among Maryland providers

Maryland providers
Behavior Technician14.1%Clinical Social Worker5.5%Student in an Organized Heal…4.5%Home Health Aide4.4%Physical Therapist3.9%Pharmacist3.6%Internal Medicine Physician2.8%
Largest specialties in Maryland (% of in-state providers)

Board certification

Not published by CMS

CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Internal Medicine Physician. Verify directly:

How MIPS and board certification work

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

Matt Wachsman, MD PHD appears in the CMS NPPES registry as an Internal Medicine Physician provider holding MD PHD credentials at 407 S UNION AVE, Havre De Grace, MD, 21078, with a listed phone of (410) 939-2141. NPI 1831225606 was issued on 02/26/2007.

Medicare Part D records for calendar year 2023 show 771 prescription claims written by this provider, covering 49 Medicare beneficiaries and totaling roughly $89K in drug spend, split 19% brand-name and 81% generic by claim count.

Internal Medicine Physician is a high-volume specialty nationwide, with 172,737 enrolled providers across 56 states and an average of 2,716 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.

Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

407 S UNION AVE
Havre De Grace, MD 21078

Provider Details

NPI 1831225606
Specialty Internal Medicine Physician
Credentials MD PHD
Gender Male
NPI Issued 02/26/2007

Brand vs generic prescribing mix · Typical

Matt Wachsman, MD PHD - brand share 19.0%
Internal Medicine Physician average

19% brand-name claims vs 81% generic, on 771 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

771
Total Claims
$89K
Total Drug Cost
49
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,085
Total Day Supply
28,371
Brand vs Generic
19% brand / 81% generic
Brand Drug Cost
$71K
Generic Drug Cost
$18K
Antibiotic Claims
64

Patient Demographics

Average Patient Age
66.7 years
Avg HCC Risk Score
1.11
Gender Split
49% female / 51% male
Age Distribution
<65: 18, 65-74: 23, 75-84: N/A, 85+: N/A

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What Matt Wachsman, MD PHD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Buprenorphine-Naloxone
Buprenorphine Hcl/Naloxone Hcl
53
Suboxone
Buprenorphine Hcl/Naloxone Hcl
49
Amlodipine Besylate
34
Enalapril Maleate
29
Montelukast Sodium
28
Hydrochlorothiazide
24
Gabapentin
23
Pantoprazole Sodium
23
Losartan Potassium
19
Cefuroxime
Cefuroxime Axetil
17

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Internal Medicine Physician Overview

How Matt Wachsman, MD PHD fits within the Internal Medicine Physician landscape nationally.

172,737
Internal Medicine Physician Providers in US
56
States with Internal Medicine Physician
2,716
Avg Claims per Provider

Matt Wachsman, MD PHD's 771 claims are below the specialty average of 2,716.

Nearby Internal Medicine Physician Providers in Maryland

Other clinicians with the same primary specialty enrolled in Maryland, drawn from the same CMS NPPES roster as Wachsman.

Compare Internal Medicine Physician nationally: see state-by-state distribution →

Before you book an appointment

Use this federal record as your verification checklist, not as a recommendation.

  • Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
  • Check the active license and any disciplinary history with the Maryland medical board, federal registration is not a license check. Credential verification guide
  • Weigh a second option: compare this provider with a nearby Internal Medicine Physician peer on Medicare volume and prescribing patterns. Compare providers

Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.

Frequently Asked Questions

What is Matt Wachsman, MD PHD's specialty?
Matt Wachsman, MD PHD specializes in Internal Medicine Physician and practices in Havre De Grace, Maryland. Credentials: MD PHD.
How much does Matt Wachsman, MD PHD prescribe under Medicare Part D?
In 2023, Matt Wachsman, MD PHD wrote 771 Medicare Part D claims totaling $89K in drug costs for 49 beneficiaries.
Where is Matt Wachsman, MD PHD located?
Matt Wachsman, MD PHD is located at 407 S UNION AVE, Havre De Grace, MD, 21078. Phone: (410) 939-2141.
What is Matt Wachsman, MD PHD's NPI number?
Matt Wachsman, MD PHD's National Provider Identifier (NPI) is 1831225606, issued on 02/26/2007.
Does Matt Wachsman, MD PHD prescribe more brand-name or generic drugs?
Matt Wachsman, MD PHD's prescribing is 19% brand-name and 81% generic drugs by claim count, with $71K in brand drug costs.
How many Internal Medicine Physician providers are there in the US?
There are 172,737 Internal Medicine Physician providers across 56 states in the US. The average Internal Medicine Physician provider writes 2,716 Medicare Part D claims per year.
What drugs does Matt Wachsman, MD PHD prescribe most often?
Based on 2023 Medicare Part D data, Matt Wachsman, MD PHD's most frequently prescribed drugs include Buprenorphine-Naloxone, Suboxone, Amlodipine Besylate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Matt Wachsman, MD PHD accept Medicare?
Matt Wachsman, MD PHD appears in CMS Medicare data with 771 Part D claims and 49 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Matt Wachsman, MD PHD's credentials?
Matt Wachsman, MD PHD's NPI is 1831225606 with credentials MD PHD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

View source datasets and methodology notes
Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology

Compiled from official public sources by the editorial process.

Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.